静脈注射用溶液の米国市場：溶液タイプ別、包装形態別（アンプル、バイアル、カートリッジ、ボトル、バッグ）、適応症別、エンドユーザー別 - 規模、シェア、見通し、機会分析（2022年～2028年）

火傷治療管理で使用される静脈注射用溶液は、タンパク質ベースのコロイド、高張液、等張晶質液などです。米国では火傷の発生件数が増加しているため、予測期間中に同市場が拡大すると予想されています。

当レポートでは、米国の静脈注射用溶液市場について調査分析し、市場力学、セグメント別の市場分析、地域別の市場分析、競合情勢などについて、体系的な情報を提供しています。

目次

第1章 調査目的・前提条件

• 調査目的
• 前提条件
• 略語

第2章 市場概要

• レポートの説明
  • 市場の定義と範囲
• エグゼクティブサマリー
  • 市場内訳：溶液タイプ別
  • 市場内訳：バッグタイプ別
  • 市場内訳：用途別
  • 市場内訳：エンドユーザー別

第3章 市場力学、規制、動向分析

• 市場力学
  • 促進要因
  • 抑制要因
  • 市場機会
• 影響分析
• 市場動向
• 主な発展
• 規制状況
• 疫学分析
• ポーターのファイブフォースモデル

第4章 米国の静脈注射用溶液市場：溶液タイプ別（2017年～2028年）

• イントロダクション
  • 市場シェア分析：2022年・2028年（％）
  • 前年比成長分析：2017年～2028年
  • セグメント動向
• 生理食塩水
  • イントロダクション
  • 市場規模・予測、前年比成長率（2017年～2028年）
  • 通常生理食塩水（0.9％ NaCl）
  • 高張食塩水
• デキストラン
• 乳酸リンゲル液
• アミノ酸
• ビタミン・ミネラル
• ヘパリン・微量元素
• 混合溶液

第5章 米国の静脈注射用溶液市場：バッグタイプ別（2017年～2028年）

• イントロダクション
  • 市場シェア分析：2022年・2028年（％）
  • 前年比成長分析：2017年～2028年
  • セグメント動向
• 大容量バッグ（250ml以上）
  • イントロダクション
  • 市場規模・予測、前年比成長率（2017年～2028年）
• 少容量バッグ（250ml未満）

第6章 米国の静脈注射用溶液市場：用途別（2017年～2028年）

• イントロダクション
  • 市場シェア分析：2022年・2028年（％）
  • 前年比成長分析：2017年～2028年
  • セグメント動向
• 基本IV溶液
  • イントロダクション
  • 市場規模・予測、前年比成長率（2017年～2028年）
• 栄養IV溶液
• 血液IV溶液
• 薬物IV溶液
• 洗浄IV溶液

第7章 米国の静脈注射用溶液市場：エンドユーザー別（2017年～2028年）

• イントロダクション
  • 市場シェア分析：2022年・2028年（％）
  • 前年比成長分析：2017年～2028年
  • セグメント動向
• 病院
  • イントロダクション
  • 市場規模・予測、前年比成長率（2017年～2028年）
• クリニック
• 外来手術センター

第8章 競合情勢

• 企業プロファイル
  • Baxter International Inc.
  • ICU Medical, Inc.
  • B. Braun Melsungen Ag
  • Grifols, S.A.
• アナリストの見解

第9章 セクション

Intravenous solutions are supplemental fluids used in intravenous therapy to restore or maintain normal fluid volume and electrolyte balance when the oral route of administration is not possible in an individual. Intravenous therapy is a medical technique that delivers fluids, medications and nutrition directly into a person's vein. Intravenous solution therapy is an efficient and effective way of supplying fluids directly into the intravascular fluid compartment of the body. Intravascular fluids are used to replace electrolyte losses, and also for administering medications and blood products. Intravenous solutions are also known as Intravenous fluids. Some of the major reasons when patient needs to take fluids intravenously, rehydration after becoming dehydrated from illness, treatment of an infection using antibiotics, cancer treatment through chemotherapy drugs, management of pain using certain medication. Fluids for such treatments consists of water with electrolytes, sugar, or medications. The amount of intravenous solution can be regulate in the body by two ways, manually or by using electric pump, which uses a pump to regulate intravenous fluid. Types of intravenous solutions are saline, dextran, lactated Ringer's, amino acid, vitamins & minerals, heparin and trace elements and mixed solutions.

Market Dynamics

The intravenous solutions used during burn care management are protein-based colloids, hypertonic solutions, isotonic crystalloids, and others. The increasing number of burn incidences in the U.S. is expected to boost the U.S. intravenous solutions market over the forecast period. For instance, according to the Burn Association of America, approximately 486,000 fire or burn injuries were reported at emergency departments in 2016 in the U.S.

However, growth of the U.S. intravenous solution market is expected to be hampered over the forecast period, owing to increasing FDA recalls. For instance, in August 2015, Covidien LLC, recalled their product Monoject 0.9% Saline Flush Prefill Double Pouch over the packaging process control reason. As there was defect in packaging of monoject 0.9% saline flush pouch.

Key features of the study:

• This report provides an in-depth analysis of global U.S intravenous solution market, provides market size (US$ Million), and compound annual growth rate (CAGR %), for the forecast period (2022 - 2028), considering 2021 as the base year.
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by leading players.
• It profiles key players in the U.S intravenous solution market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
• Key players covered as a part of this study are B. Braun Melsungen AG, Baxter International Inc., Fresenius Kabi USA, LLC, Grifols, S.A., JW Life Science, Amanta Healthcare, Salius Pharma Private Limited, Axa Parenterals Ltd., Vifor Pharma Management Ltd., Icu Medical, Inc., and Pfizer Inc.
• Insights from this report would allow marketers and management authorities of companies to make informed decisions with respect to future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
• The U.S intravenous solution market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for dialysis market, research and consulting firms, new entrants, and financial analysts.

Detailed Segmentation:

• U.S Intravenous Solution Market, By Solution Type:
  • Saline
    • Normal Saline (0.9% NaCl)
    • Hypertonic saline
  • Dextran
    • D5W (5% dextrose in water)
    • Analog Hypertonic Saline
  • Lactated Ringer's
  • Amino Acid
  • Vitamins & Minerals
  • Heparin and trace elements
  • Mixed Solutions
• U.S Intravenous Solution Market, By Packaging Type:
  • Ampules
  • Vials
  • Cartridges
  • Bottles
  • Bags
    • Large Volume Bags (greater than 250ml)
    • Small Volume Bags (less than 250ml)
• U.S Intravenous Solution Market, By Indication:
  • Oncology
  • Post-Operative Care
  • General Medicine
  • Burn Management
  • Pulmonary Disorders
  • Cardiovascular Diseases
  • Others
• U.S Intravenous Solution Market, By End User:
  • Hospitals
    • Clinics
    • Ambulatory Surgery Centres
    • Home care Settings
    • Others
• Company Profiles
  • B. Braun Melsungen AG
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
  • Baxter International Inc.
  • Fresenius Kabi USA, LLC
  • Grifols, S.A.
  • Jw Life Science
  • Amanta Healthcare
  • Salius Pharma Private Limited
  • Axa Parenterals Ltd.
  • Vifor Pharma Management Ltd.
  • Icu Medical, Inc.
  • Pfizer Inc.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

• Research Objectives
• Assumptions
• Abbreviations

2. Market Overview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Solution Type
  • Market Snippet, By Bag Type
  • Market Snippet, By Application
  • Market Snippet, By End User
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Landscape
• Epidemiology Analysis
• Porter's Five Forces model

4. U.S. Intravenous Solutions Market, By Solution Type, 2017 - 2028, (US$ Million)

• Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
• Saline
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Normal Saline (0.9% NaCl)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Hypertonic Saline
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
• Dextran
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
• Lactated Ringer's
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
• Amino Acid
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
• Vitamins & Minerals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
• Heparin and trace elements
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
• Mixed Solutions
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

5. U.S. Intravenous Solutions Market, By Bag Type, 2017 - 2028, (US$ Million)

• Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
• Large Volume Bags (greater than 250ml)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
• Small Volume Bags (less than 250ml)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

6. U.S. Intravenous Solutions Market, By Application, 2017 - 2028, (US$ Million)

• Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
• Basic IV Solution
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
• Nutritional IV Solution
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
• Blood IV Solution
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
• Drug IV Solution
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
• Irrigation IV Solution
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

7. U.S. Intravenous Solutions Market, By End User , 2017 - 2028, (US$ Million)

• Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
• Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
• Ambulatory Surgery Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
• Home care Settings
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

8. Competitive Landscape

• Company Profiles
  • Baxter International Inc.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • ICU Medical, Inc.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • B. Braun Melsungen Ag
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • Grifols, S.A.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
• Analyst Views

9. Section

• References
• Research Methodology
• About Us and Sales Contact